- Sprache
-
Englisch
- Identifier
-
1308418795
Thema
Impfstoff; Immuntherapie; Impfung
Beteiligte Personen und Organisationen
Stahl, Monika
Göpferich, Achim
Göpferich, Achim
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
09.01.2024, 09:53 MEZ
Objekttyp
- Monografie
Beteiligte
- Stahl, Monika
- Göpferich, Achim
Ähnliche Objekte (12)
Nanoparticles for drug delivery to ocular neovascularizations
Enhancing mucosal B cell responses with all-\(trans\) retinoic acid
Targeted CNS Delivery via Nanoparticulate Drug Delivery Systems
Layer by Layer fabricated gold nanoparticles for nucleic acid delivery
Heteromultivalent Nanoparticles for Selective Targeting of Renal Cells
Heteromultivalent Virus-mimetic Nanoparticles for Specific Mesangial Cell Targeting
Multivalent nanoparticles for the treatment of ocular diseases
Chemokine als Adjuvans bei der DNA-Vakzinierung : CCL19 (ELC) verbessert den tumorprotektiven Effekt einer Her-2/neu-DNA-Vakzine
Kartierung des HLA-Ligandoms der akuten myeloischen Leukämie zur Entwicklung einer therapeutischen Multipeptidvakzine
Virus-Mimetic Nanoparticles for the Therapy of Mesangial Cells in Diabetic Nephropathy
Cellular nanoparticle delivery by G-protein coupled receptors
Particulate systems for fluorescence imaging and drug delivery
Nanoparticles for drug delivery to ocular neovascularizations
Enhancing mucosal B cell responses with all-\(trans\) retinoic acid
Targeted CNS Delivery via Nanoparticulate Drug Delivery Systems
Layer by Layer fabricated gold nanoparticles for nucleic acid delivery
Heteromultivalent Nanoparticles for Selective Targeting of Renal Cells
Heteromultivalent Virus-mimetic Nanoparticles for Specific Mesangial Cell Targeting
Multivalent nanoparticles for the treatment of ocular diseases
Chemokine als Adjuvans bei der DNA-Vakzinierung : CCL19 (ELC) verbessert den tumorprotektiven Effekt einer Her-2/neu-DNA-Vakzine
Kartierung des HLA-Ligandoms der akuten myeloischen Leukämie zur Entwicklung einer therapeutischen Multipeptidvakzine
Virus-Mimetic Nanoparticles for the Therapy of Mesangial Cells in Diabetic Nephropathy
Cellular nanoparticle delivery by G-protein coupled receptors
Particulate systems for fluorescence imaging and drug delivery
Nanoparticles for drug delivery to ocular neovascularizations
Enhancing mucosal B cell responses with all-\(trans\) retinoic acid
Targeted CNS Delivery via Nanoparticulate Drug Delivery Systems
Layer by Layer fabricated gold nanoparticles for nucleic acid delivery
Heteromultivalent Nanoparticles for Selective Targeting of Renal Cells
Heteromultivalent Virus-mimetic Nanoparticles for Specific Mesangial Cell Targeting
Multivalent nanoparticles for the treatment of ocular diseases
Chemokine als Adjuvans bei der DNA-Vakzinierung : CCL19 (ELC) verbessert den tumorprotektiven Effekt einer Her-2/neu-DNA-Vakzine
Kartierung des HLA-Ligandoms der akuten myeloischen Leukämie zur Entwicklung einer therapeutischen Multipeptidvakzine
Virus-Mimetic Nanoparticles for the Therapy of Mesangial Cells in Diabetic Nephropathy
Cellular nanoparticle delivery by G-protein coupled receptors